-
1
-
-
0036244907
-
Antipsychotics and Parkinson's disease: Association with disease and drug choice during the first 5 years of antiparkinsonian drug treatment
-
van de Vijver DA, Roos RA, Jansen PA, Porsius AJ, de Boer A. Antipsychotics and Parkinson's disease: association with disease and drug choice during the first 5 years of antiparkinsonian drug treatment. Eur J Clin Pharmacol 2002;58:157-161.
-
(2002)
Eur J Clin Pharmacol
, vol.58
, pp. 157-161
-
-
van de Vijver, D.A.1
Roos, R.A.2
Jansen, P.A.3
Porsius, A.J.4
de Boer, A.5
-
2
-
-
0031865551
-
Managing the neuropsychiatric symptoms of Parkinson's disease
-
Lieberman A. Managing the neuropsychiatric symptoms of Parkinson's disease. Neurology 1998;50:S33-S38.
-
(1998)
Neurology
, vol.50
-
-
Lieberman, A.1
-
3
-
-
0034973443
-
An algorithm (decision tree) for the management of Parkinson's disease: Treatment guidelines
-
Olanow CW, Watts RL, Roller WC. An algorithm (decision tree) for the management of Parkinson's disease: treatment guidelines. Neurology 2001;56:S1-S37.
-
(2001)
Neurology
, vol.56
-
-
Olanow, C.W.1
Watts, R.L.2
Roller, W.C.3
-
4
-
-
33646107153
-
Practice parameter: Evaluation and treatment of depression, psychosis and dementia in Parkinson's disease (an evidence-based review)
-
Miyasaki JM, Shannon K, Voon V, et al. Practice parameter: evaluation and treatment of depression, psychosis and dementia in Parkinson's disease (an evidence-based review). Neurology 2006; 66:996-1002.
-
(2006)
Neurology
, vol.66
, pp. 996-1002
-
-
Miyasaki, J.M.1
Shannon, K.2
Voon, V.3
-
5
-
-
0032916601
-
Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: A community-based study
-
Aarsland D, Larsen JP, Cummins JL, Laake K. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Arch Neurol 1999;56:595-601.
-
(1999)
Arch Neurol
, vol.56
, pp. 595-601
-
-
Aarsland, D.1
Larsen, J.P.2
Cummins, J.L.3
Laake, K.4
-
6
-
-
33644875033
-
Mental health-related drug utilization among the older adult population: Prevalence, trends and costs
-
Mamdani M, Rapoport M, Shulman KI, Herrmann N, Rochon PA. Mental health-related drug utilization among the older adult population: prevalence, trends and costs. Am J Geriatr Psychiatry 2005;13:892-900.
-
(2005)
Am J Geriatr Psychiatry
, vol.13
, pp. 892-900
-
-
Mamdani, M.1
Rapoport, M.2
Shulman, K.I.3
Herrmann, N.4
Rochon, P.A.5
-
7
-
-
0032726757
-
Prevalence, clinical characteristics, and pharmacologic treatment of Parkinson's disease in residents in long-term care facilities: SAGE study group
-
Lapane KL, Fernandez HH, Friedman JH. Prevalence, clinical characteristics, and pharmacologic treatment of Parkinson's disease in residents in long-term care facilities: SAGE study group. Pharmacotherapy 1999;19:1321-1327.
-
(1999)
Pharmacotherapy
, vol.19
, pp. 1321-1327
-
-
Lapane, K.L.1
Fernandez, H.H.2
Friedman, J.H.3
-
9
-
-
0038780020
-
Treatment of psychosis in Parkinson's disease: Safety considerations
-
Fernandez HH, Trieschmann ME, Friedman JH. Treatment of psychosis in Parkinson's disease: safety considerations. Drug Safety 2003;26:643-659.
-
(2003)
Drug Safety
, vol.26
, pp. 643-659
-
-
Fernandez, H.H.1
Trieschmann, M.E.2
Friedman, J.H.3
-
10
-
-
19544378167
-
Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias
-
Aarsland D, Perry R, Larsen JP, et al. Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias. J Clin Psychiatry 2005;66:633-637.
-
(2005)
J Clin Psychiatry
, vol.66
, pp. 633-637
-
-
Aarsland, D.1
Perry, R.2
Larsen, J.P.3
-
11
-
-
0036221550
-
Atypical antipsychotics: Mechanism of action
-
Seeman P. Atypical antipsychotics: mechanism of action. Can J Psychiatry 2002;47:27-38.
-
(2002)
Can J Psychiatry
, vol.47
, pp. 27-38
-
-
Seeman, P.1
-
12
-
-
0024854809
-
The ratio of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs
-
Meltzer HY, Matrusbata S, Lee J-C. The ratio of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs. Psychopharmacol Bull 1989;25:390-392.
-
(1989)
Psychopharmacol Bull
, vol.25
, pp. 390-392
-
-
Meltzer, H.Y.1
Matrusbata, S.2
Lee, J.-C.3
|